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Endosomal escapeMost lipid formulations require cholesterol for successful transfection, but the precise reason remains to be
more clearly understood. Here, we have studied the effect of cholesterol on the transfection efﬁciency (TE)
of lipoplexes in vitro. Addition of cholesterol to highly effective DC-Chol–DOPE/DNA lipoplexes increases
TE, with 40 mol% cholesterol yielding about 10-fold improvement. The transfection mechanisms of
cholesterol-containing lipoplexes have been investigated by combining dynamic light scattering, synchrotron
small angle X-ray scattering, laser scanning confocal microscopy and transfection efﬁciency measurements.
Our results revealed that cholesterol-containing lipoplexes enter the cells partially by membrane fusion
and this mechanism accounts for efﬁcient endosomal escape. We also found evidence that formulations
with high cholesterol content are not speciﬁcally targeted to metabolic degradation. These studies will con-
tribute to rationally design novel delivery systems with superior transfection efﬁciency.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Today, one of the primary objectives of gene therapy is the devel-
opment of effective, non-toxic gene vectors that can successfully de-
liver exogenous genetic material into speciﬁc cell types, including
cancerous cells [1–3]. Viral vectors have a high efﬁciency of gene de-
livery, but important concerns have emerged over their safety [4].
This has generated massive interest in non-viral systems that exhibit
low safety risks, are capable of carrying large-size molecules and can
be produced easily and inexpensively. Among non-viral gene vectors,
cationic liposomes (CLs), which are extensively employed as in vitro
transfection agents, are emerging as promising candidates for in
vivo and ex vivo delivery of nucleic acids for a variety of applications
[5–7]. At present, the major disadvantage connected with the use of
CL–DNA complexes (lipoplexes) is their low transfection efﬁciency
(TE). This is due to the fact that a multiplicity of intracellular barriers
must be overcome to deliver exogenous DNA into the cell nucleus of
the host cell and enable its expression [8–11]. Moreover, the internal-
ization route does signiﬁcantly affect both the intracellular processing
and the ﬁnal fate of lipoplexes. Depending on the mode of cellular up-
take, internalization may alternatively lead to lysosomal degradation
or digestion, recycling back to the membrane, or delivery to other
compartments. Recently, it has been suggested that internalization: +39 06 490631.
racciolo).
rights reserved.pathways of lipoplexes are cholesterol-dependent and that cholester-
ol affects intracellular trafﬁcking of lipoplexes [12,13]. The use of cho-
lesterol in the lipoplex formulation has been shown to enhance
transfection both in vitro and in vivo [14,15]. In vitro this could be
due, at least in part, to the formation of cholesterol nanodomains in
the lipoplex membrane that may play a role either in cellular uptake
or in intracellular trafﬁcking [16–18]. In some cell lines, the incorpo-
ration of polyethylene glycol into cholesterol domains increased
transfection rates, despite the lack of enhancement of cellular uptake
[19]. The existence of such cholesterol nanodomains within lipoplex
membranes could lead to a general rethinking of current targeting
strategies. In vivo, cholesterol is believed to improve transfection by
protecting the DNA from degradation by DNAses in the body. In gen-
eral, cholesterol has been shown to be effective in reducing the bind-
ing of serum proteins to lipoplexes [20] thereby improving
transfection of DNA, both in vitro and in vivo [21]. Thus, many efforts
have been devoted to the synthesis of a series of novel cationic lipids
through the systematic substitution of cholesterol derivatives that
could greatly enhance the delivery and expression of plasmid DNA
[22]. One of the most popular cholesterol-derivative is 3β-[N-(N′,N′-
dimethylaminoethane)-carbamoyl]-cholesterol (DC-Chol) [23,24], a
cationic molecule that, both alone and combined with other lipids,
has been reported to deliver DNA efﬁciently in most cell lines
[25–35]. Beyond the widely used DC-Chol, a huge number of
cholesterol-derivatives have been synthesized [36] and successfully
used for transfection experiments both in the absence [37] and pres-
ence of helper lipids [38]. Cholesterol-based lipids with various
2336 D. Pozzi et al. / Biochimica et Biophysica Acta 1818 (2012) 2335–2343heterocyclic cationic head groups and linker types were also found to
enhance accumulation of nucleic acids in the cells [39].
In summary, most lipid mixtures seem to require cholesterol and/
or cholesterol-derivatives for successful transfection, but the precise
reason why this happens remains unclear. In this study, we provided
novel insights into the transfection mechanisms of cholesterol-
containing lipoplexes (CCLs). To this end, we used CLs made of DC-
Chol and dioleoylphosphatidylethanolamine (DOPE), one of the
most used lipoplex formulations [40,41] and we gradually replaced
DOPE molecules by cholesterol. Employing structural studies by dy-
namic light scattering (DLS) and synchrotron small angle X-ray scat-
tering (SAXS), laser scanning confocal microscopy (LSCM) and
transfection efﬁciency measurements, we were able to elucidate the
relation between efﬁciency and the transfection mechanism of CCLs.
2. Experimental section
2.1. Liposomes preparation
3β-[N-(N′,N′-dimethylaminoethane)-carbamoyl]-cholesterol
(DC-Chol) and dioleoylphosphatidylethanolamine (DOPE) were
purchased from Avanti Polar Lipids (Alabaster, AL) and used with-
out further puriﬁcation. Cholesterol was purchased in powder
form from Sigma-Aldrich (St. Louis, MO). All mixtures were pre-
pared at molar fractions of cationic lipid in the bilayer XDC-
Chol=0.5 and at molar fractions of neutral lipid in the bilayer
XDOPE+XChol=0.5, but gradually replacing DOPE molecules with
cholesterol molecules. Five different mixtures were prepared with
increasing molar fractions of cholesterol (XChol=0, 0.125, 0.25,
0.375, 0.5). Each mixture was dissolved in chloroform and the sol-
vent was evaporated under vacuum for at least 24 h. The obtained
lipid ﬁlms were hydrated with the appropriate amount of Tris–
HCl buffer solution (10−2 M, pH 7.4) to achieve the desired ﬁnal
concentration (1 mg ml−1 for all the experiments except for SAXS
experiments where it was 10 mg ml−1).
2.2. Lipoplex preparation
For transfection experiments, plasmid DNA (pGL3 which codiﬁes
for ﬁreﬂy luciferase; Promega, Madison, WI) was employed. For
SAXS experiments, calf thymus DNA (Sigma-Aldrich, St. Louis, MO)
was used. For confocal ﬂuorescence microscopy experiments, Cy5-
labeled 2.7-kbp plasmid DNA (Mirus Bio Corporation, Madison, WI)
was used. By mixing adequate amounts of the DNA solutions to suit-
able volumes of liposome dispersions, self-assembled lipoplexes were
obtained. For size and ζ-potential measurements samples were pre-
pared at seven cationic lipid/DNA charge ratio (mol/mol), that is,
ρ=(cationic lipid (by mole)/DNA base)=0.25, 0.4, 0.7, 1, 2, 3, 4. On
the basis of size and ζ-potential results, all the other experiments
were performed at ρ=3.
2.3. Size and ζ-potential
Size and size distribution of liposomes and lipoplexes were mea-
sured at 25 °C by a Malvern NanoZetaSizer spectrometer equipped
with a 5 mW HeNe laser (wavelength λ=632.8 nm) and a digital
logarithmic correlator. The normalized intensity autocorrelation
functions were detected at 90° and analyzed by using the CONTIN
method, which analyzes the autocorrelation function through an in-
verse Laplace transform [42,43] in order to obtain the distribution of
the diffusion coefﬁcient D of the particles. This coefﬁcient is converted
into an effective hydrodynamic radius RH by using the Stokes–Einstein
relationship RH=KBT/(6πηD), where KBT is the thermal energy and η
the solvent viscosity. Our clusters invariably show a size distribution,
and the values of the radii reported here correspond to the so-called
“intensity weighted” average [44]. The electrophoretic mobilitymeasurementswere carried out bymeans of the laser Doppler electro-
phoresis technique, the same apparatus used for size measurements.
The mobility u was converted into the ζ-potential using the
Smoluchowski relation ζ=uη/ε, where η and ε are the viscosity and
the permittivity of the solvent phase, respectively.2.4. Transfection efﬁciency experiments
Cell lines were cultured in Dulbecco's modiﬁed Eagle's medium
(DMEM) with Glutamax-1 (Invitrogen, Carlsbad, CA, USA) sup-
plemented with 1% penicillin–streptomycin (Invitrogen) and 10%
fetal bovine serum (Invitrogen) at 37 °C and 5% CO2 atmosphere,
splitting the cells every 2–4 days to maintain monolayer coverage.
For luminescence analysis, Chinese hamster ovary (CHO) cells
were transfected with pGL3 control plasmid (Promega, Fitchburg,
WI, USA). In order to investigate the temperature-dependence of
lipoplex uptake, CHO cells were transfected with lipoplexes at ei-
ther 37 or 4 °C. The day before transfection, cells were seeded in
24-well plates (150,000 cells per well) using medium without anti-
biotics. Cells were incubated until they were 75–80% conﬂuent,
which generally took 18–24 h. For TE experiments, lipoplexes
were prepared in Optimem (Invitrogen) by mixing for each well
of 24-well plates 0.5 μg of plasmid with 5 μl of sonicated lipid dis-
persions (1 mg ml−1). Complexes were left for 20 min at room
temperature before adding them to the cells. On the day of trans-
fection, the growth medium was replaced with 400 μl of Optimem
and the cells were incubated for 30 min at either 37 or 4 °C (keep-
ing the well plates containing cells on ice), before adding 100 μl of
lipoplexes in Optimem. Cells were incubated at either 37 or 4 °C for
an additional 4 h to permit transient transfection. Finally, to avoid
internalization of complexes that could remain bound to the cell
surface after medium replacement, the cells were extensively washed
3× with phosphate buffered saline (PBS) at the corresponding tem-
peratures (preheated at 37 °C or precooled at 4 °C) before DMEM
medium supplemented with 10% fetal bovine serum at 37 °C was
added. In experiments where methyl-β-cyclodextrin (500 μM) was
used, cells were pretreated for 30 min prior to addition of lipoplexes
and incubated during transfection (4 h) with this cholesterol-depleting
agent. After 48 h, cells were analyzed for luciferase expression using
Luciferase Assay System from Promega. Brieﬂy, cells were washed in
PBS and harvested in 200 μl 1× reporter lysis buffer (Promega). Of the
cell suspension, 20 μl was diluted in 100 μl luciferase reaction buffer
(Promega) and the luminescence was measured 10 s using a Berthold
AutoLumat luminometer LB-953 (Berthold, Bad Wildbad, Germany).
Results were expressed as relative light units per mg of cell proteins as
determined by Bio-Rad Protein Assay Dye Reagent (Bio-Rad, Hercules,
CA). Each condition was performed in quadruple and repeated three
times.2.5. Synchrotron small angle X-ray scattering
SAXS measurements were performed at the Austrian SAXS station
of the synchrotron light source ELETTRA (Trieste, Italy) [45]. SAXS
patterns were recorded with gas detectors based on the delay line
principle covering the q-ranges from qmin=0.04 Å−1 to qmax=
0.5 Å−1 with a resolution of 5×10−4 Å−1 (fwhm). The angular cali-
bration of the detectors was performed with silver behenate powder
(d-spacing of 58.38 Å). The data have been normalized for variations
of the primary beam intensity, corrected for the detector efﬁciency,
and the background has been subtracted. Exposure times were typi-
cally 300 s. No evidence of radiation damage was observed in the
X-ray diffraction patterns. The sample was held in a 1 mm glass
capillary (Hilgenberg, Malsfeld, Germany) and the measurements
were performed at 25 °C with a precision of 0.1 °C.
Fig. 1. (A) Hydrodynamic radius, RH, and (B) zeta potential, ζP, of DC-Chol–DOPE–
cholesterol/DNA lipoplexes with increasing molar fractions of cholesterol (XChol=0,
0.125, 0.25, 0.375, 0.5) as a function of the cationic lipid/DNA charge ratio, ρ.
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CHO-K1 were purchased from American Type Culture Collection
(CCL-61 ATCC) and were grown in Ham's F12K medium sup-
plemented with 10% of fetal Bovine Serum at 37 °C and in 5% CO2.
For transfection experiments, lipoplexes were prepared in PBS (Invi-
trogen) by mixing 1 μl of Cy3-labeled DNA with 10 μl of sonicated
lipid dispersions. These complexes were left for 20 min at room tem-
perature before adding them to the cells. In order to identify the
endocytic vesicles involved in lipoplex internalization, we performed
colocalization assays in living cells. CHO-K1 cells were coincubated
with lipoplexes and different endocytic ﬂuorescent markers: 1 mg/ml
70 kDa dextran-ﬂuorescein isothiocyanate (FITC) conjugate at 37 °C
for 30 min to label macropinosomes, 50 mM Lysosensor for 30 min to
label lysosomes, 2 μg/ml transferrin-Alexa488 conjugate for 30 min to
label recycling and sorting endosomes. Transfection of Caveolin-
E1GFP18 was carried out using lipofectamine reagent (Invitrogen)
according to the manufacturer's instruction. Colocalization of green
and red signals was analyzed by means of the Pearson's coefﬁcient
(Rr) using the “colocalization ﬁnder” plugin of the ImageJ software
(NIH Image; http://rsbweb.nih.gov/ij/) [46].
2.7. Laser scanning confocal microscopy experiments
Laser scanning confocal microscopy (LSCM) experiments were
performed with the Olympus Fluoview 1000 (Olympus, Melville,
NY) confocal microscope interfaced with a 405 nm diode laser, a
488 nm Argon laser, and 543 nm helium-neon laser. Glass bottom
Petri dishes containing transfected cells were mounted in a
temperature-controlled chamber at 37 °C and 5% CO2 and viewed
with a 60×1.25 numerical aperture water immersion objective. The
following collection ranges were adopted: 500–540 nm (EGFP,
Alexa488-transferrin and FITC-Dextran70 kDa), 555–655 nm (Cy3),
and 460–530 (Lysosensor). Images were collected in sequential
mode to eliminate emission cross talk between the various dyes.
3. Results
3.1. Size and ζ-potential
CLs used in the present study were found to be positively charged
(ζP≈60 mV) with a mean radius, 60 nm≤RH≤70 nm (Table 1).
Effective formulations must be positively charged with the lowest
colloidal dimensions as well. To identify the most appropriate charge
ratio for transfection, size and ζ-potential measurements of
lipoplexes were determined. In Fig. 1 the hydrodynamic radius, RH,
(panel A) and the ζ-potential, ζP, (panel B) of DC-Chol–DOPE–
cholesterol/DNA lipoplexes with increasing molar fractions of
cholesterol (XChol=0, 0.125, 0.25, 0.375, 0.5) are plotted against the
cationic lipid/DNA charge ratio. As can be seen in Fig. 1 (panel A),
with the increase of ρ, complex formation starts and the size of the
complexes gradually increases until a maximum is reached (at
ρ∼1). Further increase of the lipid content (ρ>1) determines the
formation of decreasing-size complexes until a plateau is reached (re-
entrant condensation) [47,48]. Fig. 1 (panel B) also shows the charge
inversion effect, documented by the ζ-potential values whose signTable 1
Hydrodynamic radius, RH and zeta potential, ζP, of DC-Chol–DOPE–cholesterol lipo-
somes with increasing molar fractions of cholesterol (XChol=0, 0.125, 0.25, 0.375, 0.5).
XChol RH (nm) ζP (mV)
0 60±2 58.4±0.3
0.125 67±4 60.1±0.5
0.25 70±3 62.6±0.4
0.375 62±5 64.0±0.4
0.5 65±3 64.7±0.6changes around ρ∼1, differentiating negative and positively charged
aggregates. A sigmoidal curve, similar to that previously found for
other lipoplexes can be observed [40]. This trend suggests the exis-
tence of three different ζ-potential regions: (i) the region where the
net charge of lipoplexes is negative and almost constant at about
−50 mV; (ii) the region where the inversion of ζ-potential sign
takes place (around ρ∼1); and (iii) the region where the net charge
of the lipoplexes is positive. The results reported in Fig. 1 conﬁrm
that the iso-neutrality is reached around ρ∼1, where complexes
exhibited the largest colloidal dimensions. Our results are in good
agreement with previous studies showing that lipoplexes show a
neutral charge at ρ ∼1 [49]. Lipoplexes at ρ=3 were ﬁnally chosen
because all of them exhibited positive charge (∼40 mV) as well as
the lowest colloidal dimensions (RH≤130 nm) and the lowest poly-
dispersity index (pdi∼0.2).
3.2. Transfection efﬁciency
Fig. 2 shows the transfection efﬁciency of DC-Chol–DOPE–
cholesterol/DNA lipoplexes (ρ=3) at ﬁve molar fractions of neutral
cholesterol in the lipid bilayer (XChol=0, 0.125, 0.25, 0.375, 0.5). We
held the charge of the system constant by keeping the DC-Chol con-
tent complexes unchanged (XDC-Chol=0.5), and gradually replaced
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Fig. 2. Transfection efﬁciency (TE) in RLU per mg of cellular proteins of DC-Chol–DOPE–
cholesterol/DNA lipoplexes as a function of increasing molar fractions of cholesterol
(XChol=0, 0.125, 0.25, 0.375, 0.5). TE increases over about one of magnitude with in-
creasing molar fraction of cholesterol.
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of cholesterol results in a marked enhancement of TE. Indeed, TE of
DC-Chol–DOPE/DNA lipoplexes (XChol=0) increases by a factor of 5
with the addition of only 12.5 mol% cholesterol (XChol=0.125).
Further addition of cholesterol continues to increase the TE. In an
effort to rationalize the differences in the efﬁciency shown in Fig. 2,
we ﬁrst studied the phase organization of DC-Chol–DOPE–cholesterol/Fig. 3. (A) Representative synchrotron small angle X-ray scattering patterns of DC-Chol–
lipoplexes obtained from SAXS data. The lamellar spacing decreases from 68.3 to 62.2 Å as a
ecules embedded within cationic lipid membranes. Solid lines are the best linear ﬁts to datDNA lipoplexes at the nanoscale. We were particularly interested in
whether the nanostructure of lipoplexes might correlate with their TE.3.3. Nanostructure
To shed light on the increasing proﬁle of TE versus XChol (Fig. 2), the
nanometric structure of DC-Chol-DOPE-cholesterol/DNA complexes
was investigated by means of synchrotron SAXS. Fig. 3 (panel A)
shows representative SAXS patterns of DC-Chol-DOPE-cholesterol/DNA
(XChol=0, 0.25, 0.5) at ρ=3. The sharp periodically spaced peaks at
q00l are caused by an alternating lipid bilayer–DNA–monolayer
multilamellar structure with periodicity d=2π/q00l. The broad peak
marked by an arrow results from one-dimensional (1D) ordering of the
DNA sandwiched between the lipid bilayers [50,51]. It is usually
referred to as “DNA peak” and corresponds to a DNA interhelical spacing
dDNA=2π/qDNA. Fig. 3 (panels B and C) shows the variation of d and dDNA
as a function of the molar fraction of cholesterol, XChol. As evident, both
the d-spacing and the interhelical spacing, dDNA, decrease as cholesterol
content increases. The lamellar spacing drops from 68.3 to 62.2 Å as a
function of increasing cholesterol content.
A decrease in dDNA from 38 to 31.2 Å with increasing cholesterol
content is most likely to be related to diminution of the surface area
of cationic lipid membranes [51–53]. This is expected, because the
lateral area per molecule of cholesterol (Acholesterol≈23.5 Å2) [54] isDOPE–cholesterol/DNA lipoplexes. (B) Lamellar spacing, d, of cholesterol-containing
function of increasing cholesterol content. (C) Interhelical distance between DNA mol-
a.
0.22
0.39
0.46
DC-Chol-DOPE/DNA DC-Chol-cholesterol/DNAA
B
C
Fig. 4. Colocalization of DC-Chol–DOPE/DNA and DC-Chol–cholesterol/DNA signals
(red) with endocytic markers (green). No colocalization was observed with caveolin-
E1GFP (caveolar pathway) (A) and Alexa488-transferrin (clathrin pathway) (B) while
high correlation (yellow vesicles) was observed with 70 kDa dextran (mac-
ropinocytosis) (C). The Pearson's coefﬁcient (Rr) is shown for each measurement.
Scale bar=10 μm.
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total membrane area. Lastly, we observe that no Bragg peaks arising
from cholesterol monohydrate were detected on the SAXS patterns.
This ﬁnding means that, all over the compositional range
(0≤XChol≤0.5), all cholesterol is incorporated into the lipid bilayer
and only a single liquid crystalline phase exists. Previous reports in
the literature show that, starting from XChol≈0.4, excess cholesterol
begins to coexist with lipoplexes as cholesterol monohydrate crystals.Our structural ﬁndings therefore suggest that the solubility of choles-
terol in DC-Chol-rich membranes is higher than in other cationic lipid
membranes used for transfection [17–19,56]. Since the presence of
cholesterol-rich nanodomains may affect both the cellular uptake
and the intracellular trafﬁcking of lipoplexes [16–18], this ﬁnding
might be extremely signiﬁcant for the rational design of lipid gene
vectors.
3.4. Uptake mechanism
To clarify the role of cholesterol on the cellular uptake of
lipoplexes we used a complementary approach including LSCM and
transfection efﬁciency experiments. To stress possible differences in the
uptake mechanism, experiments were performed on DC-Chol–DOPE/
DNA and DC-Chol–cholesterol/DNA lipoplexes, as these formulations
exhibit the largest difference in the cholesterol content (XChol=0 and
0.5, respectively). Intracellular trafﬁcking of ﬂuorescently labeled
lipoplexes (red) in living cells in the presence of various endocytic
markers (green) was investigated by LSCM. The degree of colocalization
of green and red ﬂuorescence signals was quantiﬁed by means of the
Pearson's coefﬁcient (Experimental section). First, a transfection with
caveolin-E1GFP was used to label caveolae. At 1 h of treatment with
lipoplexes, (Fig. 4, panel A) no clear colocalization of red and green
ﬂuorescent signals was found, indicating that both DC-Chol–DOPE/DNA
and DC-Chol–cholesterol/DNA lipoplexes were not taken up, at least
signiﬁcantly, through this pathway. Correlation analysis of confocal
images conﬁrmed this suggestion (average Pearson's coefﬁcients are
reported in Fig. 4).
To investigate if lipoplexes enter cells via the clathrin-coated
vesicle-mediated endocytosis pathway, Alexa488-labeled transferrin,
marker for clathrin dependent endocytosis, was used. To avoid mis-
leading interpretation experiments were performed 30 min after
treatment with lipoplexes. Such reduction in the incubation time is
motivated by the fact that macropinosomes may reach the clathrin-
positive endosomal checkpoint with time, and might give rise to a
misleading increase of the degree of colocalization. Again, as reported
in Fig. 4, panel B, the two ﬂuorescence signals remained largely
uncolocalized, suggesting that the clathrin pathway is not signiﬁcant-
ly involved in the cellular uptake of neither DC-Chol–DOPE/DNA and
DC-Chol–cholesterol/DNA lipoplexes.
Finally, macropinocytosis was visualized by treating cells with a
ﬂuorescently-labeled 70-kDa dextran. Since macropinocytosis is a
ﬂuid phase uptake, it is expected to be a slower process. Thus,
LSCM experiments were performed after incubating the lipoplexes
with cells for varying time periods of 15 min, 30 min, 1 h and 3 h.
At t=3 h we observe that both the lipoplex formulations col-
ocalized with dextran in living cells, although with a difference in
the overall amount of correlation between the two signals (Fig. 4,
panel C). In detail, despite their higher transfection efﬁciency, DC-
Chol–cholesterol/DNA lipoplexes show a decreased colocalization
with the macropinosome marker compared to that of DC-Chol–
DOPE/DNA ones (Rr=0.11±0.09 vs Rr=0.39±0.08, Table 2).
This apparent discrepancy is explained by the presence of large
(μm-sized) red patches around several macropinosomes in the
case of DC-Chol–cholesterol/DNA lipoplexes (see zoomed detail in
Fig. 4, panel C). Besides providing an explanation for the reduction in
the colocalization factor, this effect strongly suggests that cholesterol-
enriched lipoplexes are capable of efﬁcient and early escape from
macropinosomes. At this stage, it is worth noting that similar “escape”
patches are also present in the colocalization assays with caveolin-
E1GFP and transferring-green, but with the obvious absence of correla-
tion (i.e. absence of contribution of the caveolar and clathrin routes).
Since it has been recently shown that lipoplex macropinocytosis is
a cholesterol-sensitive uptake mechanism [57] we asked whether
cholesterol depletion could have an effect on the cellular uptake of
CCLs. Cholesterol depletion on the plasma membrane by methyl-β-
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Fig. 5. (A) Reduction in transfection efﬁciency (TE) of cholesterol-containing lipoplexes
expressed by the ratio between the TE measured in cells treated with methyl-β-
cyclodextrin, TECD, and thatmeasured in nontreated cells, TENT, as a function of increasing
molar fractions of cholesterol (XChol=0, 0.125, 0.25, 0.375, 0.5). (B) Temperature-
independent TE measured at 4 °C in RLU per mg of cellular proteins of DC-Chol–DOPE–
cholesterol/DNA lipoplexes as a function of increasing molar fractions of cholesterol
(XChol=0, 0.125, 0.25, 0.375, 0.5). DC-Chol-DOPE/DNA DC-Chol-cholesterol/DNAA
B
C
2340 D. Pozzi et al. / Biochimica et Biophysica Acta 1818 (2012) 2335–2343cyclodextrin had a dramatic effect on the TE of lipoplexes. Fig. 5 panel
A shows the reduction in TE expressed by the ratio between the TE of
treated, TECD, and that nontreated cells, TENT. Remarkably, the TECD/
TENT efﬁciency ratio did directly correlate with the cholesterol con-
tent: the higher the cholesterol content, the higher the reduction in
TE. These ﬁndings indicate a key role of cholesterol in the lipoplex up-
take and subsequent trafﬁcking.
As explained above, our ﬂuorescence-based colocalization assays
reveal that DC-Chol–cholesterol/DNA lipoplexes (Fig. 4, right
panels) have a high propensity to form large intracellular structures,
at least part of which is associated with macropinosomes. In this
connection it is important to consider that, in addition to
endocytosis, several different pathways, probably mediated by
direct fusion between lipoplexes and the plasma membrane, have
been suggested as alternative routes for the functional delivery of
genetic material [58]. Endocytosis is a temperature-dependent (TD)
process (it does not take place at 4 °C), while direct transport through
the plasma membrane is supposed to be a temperature-independent
(TI) process, as it occurs even at low T [59–63]. A common way to
probe the existence of TI uptake mechanisms is to perform TE exper-
iments at 4 °C. When cells were transfected at 4 °C, all the lipoplex
formulations transfected cells efﬁciently (Fig. 5, panel B). According
to literature, this ﬁnding is likely to suggest that CCLs enter cells, at
least partially, via a mechanism other than endocytosis. Remarkably,Table 2
Pearson's coefﬁcients for lipoplexes colocalization with endocytic markers. The num-
ber of cells used for the calculation is reported in parentheses.
Caveolin Transferrin Dextran
DC-Chol–DOPE/DNA −0.01±0.05 (7) 0.06±0.05 (10) 0.39±0.08 (10)
DC-Chol–cholesterol/
DNA
−0.46±0.15 (7) −0.39±0.07 (7) 0.11±0.09 (13)TI-TE monotonically increasedwith increasingmolar fraction of choles-
terol, thus suggesting that TI-mechanisms are favored in cholesterol-
enriched formulations. In particular, the addition of only 12.5 mol%
cholesterol affords a 4-fold raise in the TI-TE factor.
In summary, our ﬁndings about the cellular uptake of CCLs can be
summarized as follows: CCLs use either (i) a cholesterol-dependent
macropinocytosis pathway and (ii) a TI mechanism to enter cells.
The latter mechanism does strictly correlate with cholesterol content:
speciﬁcally, the higher the cholesterol content of lipoplexes, the
higher their TI-TE.3.5. Intracellular ﬁnal fate
To account for differences in TE, the ultimate intracellular fate of
lipoplexes was ﬁnally evaluated. To this end, colocalization of DC-Chol–
DOPE/DNA and DC-Chol–cholesterol/DNA lipoplexes with Lysosensor
(lysosome marker, green) was investigated. After 3 h of incubation
with DC-Chol–DOPE/DNA lipoplexes, minor colocalization of red and
green signals was observed, together with detectable lipoplex escape
from lysosomes, as testiﬁed by the large uncolocalized red patches
(Fig. 6). This observation provides a reasonable explanation for their
good TE (Fig. 1) [64]. Strikingly, when cells were transfected with DC-
Chol–cholesterol/DNA lipoplexes no colocalization with Lysosensor was
found. This observation was fully supported by correlation analysis of
confocal images. Remarkably, Fig. 6 shows typical morphological
changes of DC-Chol–cholesterol/DNA lipoplexes that appear as
extremely large structures (typically>2 μm). Such large structures areFig. 6. Colocalization of DC-Chol–DOPE/DNA and DC-Chol–cholesterol/DNA signals
(red) with Lysosensor (lysosome marker, green), after 3 h of lipoplex treatment (A).
Both the lipoplex formulations are able to avoid lysosomal entrapment (B). When
cells are treated with DC-Chol–cholesterol/DNA lipoplexes large structures arise from
extensive membrane reorganization (C). Scale bar=10 μm.
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formation could arise from extensive membrane reorganization [65].
The complete absence of colocalization of the DC-Chol–cholesterol/
DNA lipoplexes with Lysosensor demonstrates that this formulation is
not speciﬁcally targeted to metabolic degradation. Together with the
lower degree of colocalization with macropinosomes and the observed
contribution of a TI mechanism, these data again support the higher
transfection efﬁciency of cholesterol-enriched lipoplexes.
4. Discussion
Previous studies have shown that lipoplexes with high levels of
cholesterol and/or cholesterol-derivatives exhibited enhanced trans-
fection [66–70] and resistance to serum-induced aggregation
[71,72]. While the involvement of cholesterol in numerous cellular
mechanisms and processes is well established, the reason why it
should improve the transfection efﬁciency of lipid gene vectors has
not been clariﬁed so far. The rationale for this study was thus to better
understand the molecular mechanisms governing the cellular uptake
and the ﬁnal fate of CCLs. This in turn would help to identify critical
steps that could be pharmacologic targets for improved transfection.
To this end, we used CL formulations made of the cationic lipid DC-
Chol, and the neutral lipid DOPE, and we gradually replaced DOPE
molecules by cholesterol. It is known that several physical–chemical
parameters control lipofection. Among them, lipid/DNA charge ratio,
size and zeta-potential can dramatically affect TE. To avoidmisleading
interpretations, we kept lipid/DNA charge ratio, size and zeta-
potential constant. Hence, we performed an accurate preliminary
characterization concerning the size and the ζ-potential of the lipid/
DNA supramolecular aggregates (Fig. 1). Upon lipoplex formation,
both reentrant condensation and charge inversion occurred (Fig. 1).
The proper lipoplex formulations for transfection studies were chosen
according to the following general considerations: (i) lipoplexes must
be positively charged to associate electrostatically with mammalian
cells, which contain surface proteoglycans with negatively charged
sulfated groups; (ii) excess amount of cationic lipid (i.e. large ρ
values) is detrimental in terms of lipid toxicity to the cells; and
(iii) homogeneous small-size complexes are better internalized and
processed by cells. As a result, lipoplexes at ρ=3 were selected be-
cause all of them exhibited a positive charge (∼40 mV) as well as
the lowest colloidal dimensions (RH≤130 nm) and the lowest poly-
dispersity index (pdi∼0.2). Recent studies clearly show that, in a
given cell line, internalization and uptake kinetics of nanoparticles
are highly size-dependent [73]. Thus, since size of CCLs remain almost
unchanged with increasing molar fractions of cholesterol, this param-
eter could not be taken into account to explain differences in their
cellular uptake, ﬁnal fate and TE.
When lipoplexes were given to cells, all the formulations yielded
high TE (Fig. 2). Remarkably, a clear TE enhancement can be observed
for 0 bXCholb and 0.375, and no further TE increase is clearly seen for
XChol>0.375. This result is in good agreement with previous ﬁndings
showing that TE of CCLs raises up to XChol≈0.4 [56]. In an effort to ra-
tionalize the differences in the efﬁciency shown in Fig. 2, weﬁrst studied
the phase organization of DC-Chol–DOPE–cholesterol/DNA lipoplexes.
We were particularly interested in whether the nanostructure of
lipoplexes might correlate with their TE. In fact, one possible
explanation for the increase in TE could be a phase transition, promoted
by cholesterol, toward a non-lamellar most transfecting phase [74–77].
SAXS experiments showed that lipoplexes remained lamellar with in-
creasing cholesterol content and no phase transition occurred (Fig. 3,
panel A). However, we observed that the interlamellar periodicity d de-
creased more than 6 Å with increasing XChol (Fig. 3, panel A), due to the
reduced hydration layer of cholesterol molecules [56]. At small inter-
membrane distances, the presence of a strong repulsive force commonly
knownas the “hydration force” represents amajor barrier formembrane
interaction and fusion. This repulsive interaction between lipidmembranes is probably the result of lipid molecules perturbing the
water structure close to the lipid–water interface. It has also been
suggested that the hydration force is due to a partial charge transfer be-
tween the lipid polar headgroups and thewater molecules resulting in a
sort of “chemical hydration” of the bilayer surface.When DOPE gets rep-
laced by cholesterol, the average hydration repulsion layer of the mem-
brane is reduced leading to a reduced hydration repulsion and thus
enhanced fusion of the cationic membranes of lipoplexes with the an-
ionic cellular membranes [56,78]. In this light, cholesterol-rich
lipoplexes are expected to be favored in the interaction with the cellular
membranes, thus facilitating fusion-driven cellular uptake and/or
endosomal release, depending on the mechanism of entry coming into
play. To clarify this point, we investigated the cellular uptake and ﬁnal
fate of lipoplexes. By a combination of imaging and pharmacological ap-
proaches we have demonstrated that the main endocytic pathway in-
volved in CCLs' internalization and trafﬁcking is cholesterol-dependent
macropinocytosis (Fig. 4). When the ﬁnal fate of CCLs was investigated,
however, nomarked colocalizationwith lysosomeswas found (Fig. 6), in
keeping with the purported escape ability of both DC-Chol–DOPE/DNA
and DC-Chol–cholesterol/DNA formulations. At this stage, by confocal
imaging we registered a higher propensity of DC-Chol–cholesterol/
DNA to form large intracellular structures or plaques compared to DC-
Chol–DOPE/DNA. This is testiﬁed by a detectable reduction in the
colocalization of lipoplexes with macropinosomes at higher
cholesterol concentrations. This in turn suggests either an early
release from vesicles and/or the concomitant existence of a vesicle-
independent process.
Notably, TE experiments performed at 4 °C, where endocytosis
does not take place, demonstrated the presence of a TI pathway that
is progressively favored by increasing amounts of cholesterol in the
lipoplex formulation (Fig. 5, panel B). Even though the lipoplex–cellular
membrane interaction accounting for the TI transfection is presently
unknown, it is most likely controlled by lipid mixing between lipoplex
and cellular lipids. Resina et al. assumed that the TI-TE of Neutraplex
lipoplexes [63], which are second generation highly-effective gene vec-
tor systems, might be due to lipid mixing and concomitant membrane
fusion. Indeed, lipids mix quickly during individual hemifusion/fusion
events and lipid mixing is usually taken as an indication of membrane
fusion. This suggestion is further supported by a recent study by Ming
et al. who showed that oligonucleotides delivered by lipoplexes enter
the cells partially by membrane fusion [79]. Given the high TI-TE of
cholesterol-containing lipoplexes, it is conceivable to hypothesize that
a mechanism of direct fusion between lipoplexes and cellular mem-
branes plays a role also at higher temperature, thus explaining the
transfection efﬁciency boost observed at 37 °C (Fig. 1).
Taken together, our results put forth the concept that cholesterol
can act as promoter of lipoplex fusion with both the plasma and the
endosomal membranes. This idea is further strengthened by several
results present in literature, as discussed in the following. First, it
has been demonstrated that cholesterol is able to promote and stabi-
lize local bilayer negative curvature (bending), a crucial step during
the membrane fusion process [79,80]. Membrane fusion proceeds by
means of intermediates in which the proximal leaﬂets of the fusing
membranes are merged, whereas the distal leaﬂets are separate (fu-
sion stalk), followed by the opening of small aqueous “fusion pores”
that might be determinant for the cytosolic release of the gene pay-
load [81]. Accordingly, it has been recently shown that addition of
cholesterol in phospholipid membranes facilitates the formation of
bicontinuous cubic phases at physiological temperatures and in-
creases their ability for fusion [82]. The role of cholesterol in promot-
ing membrane fusion has been a matter of frequent investigation in
the ﬁeld of viral vector-mediated gene transfer. It is worth mention-
ing that several enveloped viruses rely on the presence of cholesterol
to promote their own entry into cells [83–85]. Indeed, cholesterol de-
pletion has been found to inhibit fusion of vaccinia virus (VACV) with
plasma membrane [86]. Also, successful infection by inﬂuenza virus
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lyzes fusion between the viral envelope and the intracellular
endosomal membrane of the target cell, thus creating a pore large
enough to release the viral genome [86]. While the association of
HA with cholesterol-rich domains does explain why the virus infec-
tivity is inhibited by cholesterol depletion, the role of cholesterol
seems to be even more important than this. Cholesterol acts at two
stages in membrane fusion: (1) early, prior to fusion pore opening,
it promotes the formation and growth of the contact sites needed
for lipid mixing and (2) late, it helps to expand the fusion pore, there-
by increasing the efﬁciency of fusion. In light of these ﬁndings, we are
prompted to conclude that, in our system, cholesterol facilitates
lipoplex–cellular lipid mixing leading to membrane fusion at the level
of both the plasma and endosomal membranes. Very similar results
have been recently achieved with pyridinium-based lipoplexes that
promote transient permeabilization of cells and allow deep tissue
penetration [87,88]. As a matter of fact, our results suggest that the
role of cholesterol on lipofection resembles that played in the early
steps of cellular infection by viruses.
5. Conclusions
In conclusion, we have shown that CCLs use either (i) a
cholesterol-dependent macropinocytosis pathway and (ii) a TI mech-
anism to enter cells. The latter mechanism is strictly related with cho-
lesterol content: the higher the cholesterol content of lipoplexes, the
higher their TI-TE. We also found evidence that formulations with
high cholesterol content are not speciﬁcally targeted to metabolic
degradation. This mechanism of action of CCLs should be considered
for the rational design of novel delivery systems with superior trans-
fection efﬁciency. It has recently been shown that nanoparticle up-
take and cellular processing are both affected by the cell cycle [89]
that is, in turn, largely regulated by cholesterol. Furthermore,
nanoparticles of the same type are differently uptaken in different
cell types [90]. Experiments aimed at evaluating the role of cell
cycle and type on the uptake and ﬁnal fate of cholesterol-containing
lipoplexes are currently in progress in our laboratories.
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